Found 105 matching trials
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers
PHASE1This is an open-label, multi-center study to evaluate the safety, tolerabil...
Location
USC/Norris Comprehensive Cancer Center
Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas
PHASE1Progress in the treatment of children with leukemia and lymphoma results in...
Location
National University Hospital
to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)
PHASE2To see the safety and efficacy of injecting MG4101 as a secondary treatment...
Location
Samsung Medical Center
Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML
PHASE1This phase 1/2 study is testing a new treatment for acute myeloid leukemia ...
Location
Nationwide Children's Hospital
NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial
PHASE2Acute Myeloid Leukemia (AML) is a complex and rapidly progressive disease w...
Location
Hospital de Clinicas de Porto Alegre
Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors
PHASE1This phase I trial studies the side effects and best dose of expanded natur...
Location
M D Anderson Cancer Center
KN5501 Cell Injection for Refractory SLE(CLEAR)
PHASE1The goal of this clinical trial is to learn about the safety, pharmacokinet...
Location
Bengbu Medical College First Affiliated Hospital
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
N/AThis is a non-interventional observational study aiming to evaluate the qua...
Location
Seoul St. Mary Hospital
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia
EARLY_PHASE1This study is a prospective, single-center, single-arm exploratory clinical...
Location
Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences
Reactivating NK Cells in Treating Refractory Head and Neck Cancer
PHASE1This study aims to determine the safety and efficacy of expanded activated ...
Location
National University Hospital